Clinical Oncology Next-Generation Sequencing Market Growth...

Clinical Oncology Next-Generation Sequencing Market Growth Scenario, Industry Size, Share Analysis, Trends, Competitive Analysis and Forecasts to 2030

Posted 2024-03-05 07:23:22

164

Clinical Oncology Next-Generation Sequencing Market Report Overview:

The research gives a comprehensive analysis of the Clinical Oncology Next-Generation Sequencing Market, including dynamic patterns, industry landscape, and all main market features. The Clinical Oncology Next-Generation Sequencing market research report also offers a thorough examination of the key players.

Grab your free sample copy of this report now @ https://www.maximizemarketresearch.com/request-sample/100383

Estimated Revenue Growth:

The Clinical Oncology Next-Generation Sequencing Market size was valued at USD 9.49 Billion in 2023 and the total Clinical Oncology Next-Generation Sequencing revenue is expected to grow at a CAGR of 20.7 % from 2024 to 2030, reaching nearly USD 35.42 Billion by 2030.

Clinical Oncology Next-Generation Sequencing Market Dynamics:

Rising global cancer burden boosts demand for precise genomic analysis, propelling clinical oncology next-generation sequencing market growth.

Continuous improvements in NGS technology are boosting the Clinical Oncology Next-Generation Sequencing Market. For example, Illumina's NovaSeq platform will revolutionise cancer genome analysis by increasing sequencing speed and accuracy. This innovation propels market expansion by allowing for speedy and cost-effective genomic profiling in oncology research and clinical applications. The rising worldwide cancer burden, particularly in emerging countries, increases the need for accurate genomic analysis afforded by NGS. Thermo Fisher's Oncomine tests, which provide full molecular profile, address this requirement by facilitating targeted therapy selection and monitoring, hence accelerating market expansion amid escalating cancer incidence estimates.

Clinical Oncology Next-Generation Sequencing Market Scope and Research Methodology:

The aim of this report is to assess and predict the size of the Clinical Oncology Next-Generation Sequencing market. It offers strategic profiles of significant market participants to provide an accurate depiction of the competitive landscape within the global Clinical Oncology Next-Generation Sequencing market. This includes a comprehensive analysis of recent developments such as new product launches, acquisitions, mergers, joint ventures, brand activities, and major players in the Clinical Oncology Next-Generation Sequencing industry. The report presents insights into industry trends, dynamics, and potentials, assisting professionals in staying informed about the latest trends and sector performance. This insight aids in predicting growth and decline in Clinical Oncology Next-Generation Sequencing market share over the forecast period.

In-depth understanding of the Clinical Oncology Next-Generation Sequencing industry was achieved through a combination of primary and secondary research methods. Various methodologies, including PESTLE, PORTER, and SWOT analysis, were employed to ensure accurate findings. SWOT analysis was employed to outline strengths, weaknesses, opportunities, and challenges for key players within the Clinical Oncology Next-Generation Sequencing industry. Additionally, the use of PORTER and PESTLE analysis allowed for an understanding of the microeconomic and macroeconomic factors influencing the Clinical Oncology Next-Generation Sequencing industry.

For a deeper understanding, click on the link below:

Clinical Oncology Next-Generation Sequencing Market Segmentation:

by Technology
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing
Others

by Workflow
Pre-Sequencing
Sequencing
Data Analysis

by Application
Screening
Diagnostics

by End-User
Hospitals
Clinics
Laboratories

Based on technology, Whole Genome Sequencing dominated the Clinical Oncology Next-Generation Sequencing Market in 2023. It provides a comprehensive view of an individual's entire genome, allowing for the identification of novel mutations and complex structural variations, but its adoption is hampered by high costs and extensive data analysis. Whole Exome Sequencing (WES) focuses on sequencing the genome's protein-coding regions, providing a balance of cost-effectiveness and extensive genomic coverage, making it ideal for finding cancer-related coding mutations. Targeted Sequencing, on the other hand, selectively reads specific regions of interest, resulting in excellent sensitivity and cost efficiency, especially when discovering known cancer-associated mutations. Other developing technologies, like as RNA sequencing or single-cell sequencing, provide additional insights into tumour biology and heterogeneity, however with

Clinical Oncology Next-Generation Sequencing Market Key Players:

Major Contributors in the Clinical Oncology Next-Generation Sequencing Industry in North America:
1. Illumina, Inc.., San Diego, California, USA
2. Thermo Fisher Scientific, Inc., Waltham, Massachusetts, USA
3. Guardant Health, Inc., Redwood City, California, USA
4. PPacific Bioscience of California, Inc., Menlo Park, California, USA
5. Agilent Technologies, Inc., Santa Clara, California, USA
Leading players in the Europe Clinical Oncology Next-Generation Sequencing Market:
1. Qiagen N.V., Venlo, Netherlands
2. Roche Holdings AG (including Foundation Medicine), Basel, Switzerland
3. Oxford Nanopore Technologies Ltd., Oxford, United Kingdom
4. Genewiz Germany GmbH, Leipzig, Germany
5. Sophia Genetics SA, Saint-Sulpice, Switzerland
Key players driving the Asia-Pacific Clinical Oncology Next-Generation Sequencing Market:
1. Novogene Corporation, Beijing, China
2. BGI Group, Shenzhen, China
3. Takara Bio Inc., Kusatsu, Japan
4. MedGenome Labs Pvt. Ltd., Bengaluru, India

Clinical Oncology Next-Generation Sequencing Market Regional Perspectives:

The report is segmented into several key countries, with market size, growth rate, import and export of Clinical Oncology Next-Generation Sequencing market in these countries, which covering North America, U.S., Canada, Mexico, Europe, UK, Germany, France, Spain, Italy, Rest of Europe, Asia Pacific, China, India, Japan, Australia, South Korea, ASEAN Countries, Rest of APAC, South America, Brazil, and Middle East and Africa.

Request For Sample Link: https://www.maximizemarketresearch.com/request-sample/100383

Key Questions answered in the Clinical Oncology Next-Generation Sequencing Market Report are:

Which segment grabbed the largest share in the Clinical Oncology Next-Generation Sequencing market?
Which segment is expected to grow at a high rate during the forecast period?
How is the competitive scenario of the Clinical Oncology Next-Generation Sequencing market?
Which are the key factors driving the Clinical Oncology Next-Generation Sequencing market growth?
Which are the factors restraining the Clinical Oncology Next-Generation Sequencing market growth?
Which region holds the maximum share in the Clinical Oncology Next-Generation Sequencing market?
What will be the CAGR of the Clinical Oncology Next-Generation Sequencing market during the forecast period?
Which are the prominent players in the Clinical Oncology Next-Generation Sequencing market?

Key Offerings:

A detailed Analysis of the Market Overview
Market Share, Size Forecast by Revenue | 2024−2030
Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
Market Segmentation – A detailed analysis by Route of administration, Application, Facility of use and Region and Region
Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Table of Content: Clinical Oncology Next-Generation Sequencing Market

Part 01: Executive Summary

Part 02: Scope of the Clinical Oncology Next-Generation Sequencing Market Report

Part 03: Clinical Oncology Next-Generation Sequencing Market Landscape

Part 04: Clinical Oncology Next-Generation Sequencing Market Sizing

Part 05: Clinical Oncology Next-Generation Sequencing Market Segmentation by Type

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

sales@maximizemarketresearch.com

+91 96071 95908, +91 9607365656

Please log in to like, share and comment!